Cell and gene therapy development: four Asian markets to look out for
Gene therapy involves introducing new genetic material into cells so that abnormal genes causing bad protein-coding functions are altered, replaced or silenced. It is most active in the treatment of cancer, accounting for over 60 percent of clinical trials and over 50 percent of all approved therapies worldwide. Starting in the early 2000s, countries in…
